Quest Diagnostics (DGX) Tops Q1 EPS by 15c; Raises FY17 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Quest Diagnostics (DGX) Tops Q1 EPS by 15c; Raises FY17 EPS Outlook
April 24, 2017 9:35 AM EDT
Canaccord Genuity raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $102.00) while maintaining a Buy rating, following the company's first quarter report.
Analyst Mark Massaro notes the company provided one of its best earnings reports in 4 years, delivering first quarter... More
April 24, 2017 9:14 AM EDT
UBS raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $102.00) while maintaining a Buy rating, following a company update post first quarter results.
Analyst A.J. Rice notes management's strong execution of growth opportunities such as hospital deals that could... More
April 21, 2017 9:15 AM EDT
Barclays raised its price target on Quest Diagnostics (NYSE: DGX) to $100.00 (from $98.00) while maintaining a Equalweight rating following the company's first quarter earnings.
Analyst Jack Meehan notes the company provided a sizable beat on volume relative to expectations driven by the best headline... More
April 21, 2017 8:26 AM EDT
Deutsche Bank raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $108.00) while maintaining a Buy rating.
...
More
April 20, 2017 1:03 PM EDT
Evercore ISI raised its price target on Quest Diagnostics (NYSE: DGX) to $104.50 (from $102.00) while maintaining an In Line rating.
Analyst Ross Muken said DGX has become one of the most consistent companies in healthcare. That said, valuation keeps them on the... More
